BioSpace News Archive

CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the first quarter of 2024.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, will hold its first quarter earnings conference call on Tuesday, May 7, 2024 at 4:30pm ET.

The global cell expansion market size was evaluated at US$ 17.61 billion in 2023 and is expected to attain around US$ 56.16 billion by 2033, growing at a CAGR of 12.32% from 2024 to 2033

Bionano Genomics, Inc. announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the RBC Capital Markets 2024 Global Healthcare Conference on May 15, 2024.

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, announced that it will release its first quarter 2024 financial results and provide a company update after the market closes on Tuesday, May 7, 2024.

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2024.

CooperCompanies announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET.

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it will release its first quarter 2024 financial results after market close on Tuesday, May 14, 2024.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies (“CGT”) and broader biopharma markets, today announced the Company’s first quarter 2024 financial results will be released after market close on Thursday, May 9, 2024.

The Board of Directors of BD, a leading global medical technology company, announced it has declared a quarterly dividend of $0.95 per common share, payable on June 28, 2024 to holders of record on June 10, 2024.